- Investing Ideas
- /
- U.K. Pharmaceuticals & Biotech Undervalued over 20% based on DCF
U.K. Pharmaceuticals & Biotech Undervalued over 20% based on DCF
Results
1
1 new
Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.
1 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
GNS New | UK£18.10 | -8.6% | -17.9% | UK£1.2b | UK£26.33 | PE150.5x | E37.0% | 1.8% |
Page 1 of 1